Keywords: b-ms/sanofi, withdraw, avapro, filing, bristol-myers, squibb, sanofi-synthelabo

B-MS/Sanofi withdraw Avapro filing

Article | 11 February 2002

Bristol-Myers Squibb and Sanofi-Synthelabo have decided to withdrawtheir application to market their angiotensin II receptor antagonist Avapro (irbesartan) in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing

Related Drugs

Avapro

irbesartan

Efavirenz

Sustiva

Go to drug listing